Smartwatches vs. heart disease: brazilian study tests AI-Powered early warning system

NCT ID NCT07174206

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study is testing whether a smartwatch, combined with artificial intelligence and remote doctor check-ins, can help detect heart issues like atrial fibrillation and unstable angina earlier than usual. Researchers at the University of Sao Paulo will enroll 520 adults with heart conditions or recent heart procedures. Participants will wear a smartwatch and a portable heart monitor for up to 45 days, and doctors will be alerted if the watch detects something concerning. The goal is to see if this approach is practical, accurate, and could improve patient care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Smartwatch and portable holter devices for heart monitoring

What this could lead to

If successful, this could show that smartwatches and AI can help doctors catch heart rhythm problems early and manage patients remotely, potentially reducing hospital visits.

What could go wrong

This is an early feasibility study, not a large treatment trial. The smartwatch may miss some heart events or cause false alarms, and results may not apply to all heart patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Arrhythmias, Cardiac atrial fibrillation cardiovascular disorder heart disorder intermediate coronary syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Instituto do Coracao, HCFMUSP

    RECRUITING

    São Paulo, São Paulo, 05403-900, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••